Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
When it comes to COVID-19 detection, time is critical. This week, Diagnostic Imaging speaks with the leadership of RADLogics about their current artificial intelligence (AI) system that is designed to streamline workflow. CEO Moshe Becker shares not only the benefits of the system for radiologists, but also the impact on patient care. In addition, he also addresses what makes this AI system different from others in light of a new study that calls the efficacy and accuracy of COVID-19-related machine learning into questions. Look for the interview later this week.
For more COVID-19 AI coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
Recent research has shed a great deal of light on the role of the blood-brain barrier in brain aging diseases. This week, new investigative findings will be published about the impact of having a faulty blood brain barrier and how it might affect the brain. Look for details later this week.
For more coverage of the blood brain barrier, click here.
While tuberculosis is rare in the United States, that isn’t necessarily the case around the world. And, individuals who have active infections pose a dangerous risk to those around them. In a study to-be-published later this week, investigators take a deeper look at how the use of chest X-ray or chest CT allow for more timely screenings and diagnosis. Look for the story later this week.
For additional tuberculosis coverage, click here.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.